Boston, MA (PRWEB) September 27, 2013
Cambridge Semantics, leading provider of Smart Data software solutions for enterprises, along with co-host Linguamatics, the top provider of market-leading text analytics software, today announced a free online webinar focusing on CI Informatics; providing a deeper, more comprehensive approach to competitive intelligence (CI) using semantic analysis.
Guy Singh, Senior Product Manager for Linguamatics, and Ben Szekely, Director and Founding Engineer at Cambridge Semantics will present on how the rise of semantic technologies enables the linking, identification, extraction and analysis of critical information in a quicker, more comprehensible way. The webinar provides an overview and a live demo of how text mining and semantic analysis can be used for competitive intelligence.
Wednesday, October 2, 2013
11:00 a.m. – 12:00 p.m. ET (8:00 a.m. – 9:00 a.m. PT)
Professionals working in the area of competitive intelligence, including Informaticians, Information Professionals, and Researchers and Managers from the Pharmaceutical sector
Register online to reserve your spot today
Details: Competitive intelligence on products, companies and strategic areas is a time consuming business due to the large number of diverse sources and changing requirements. However, unlike traditional informatics practices in Pharma, CI does not have the same level of robust software tools and rigorous methodologies. This webinar looks at how the rise of semantic technologies fills this gap by enabling the linking, identification, extraction and analysis of critical information in a quicker, more comprehensible way.
Linguamatics' agile NLP-based text mining software, I2E, identifies and extracts the most relevant information from a wide range of unstructured sources. Cambridge Semantics' Anzo Pharma Competitive Intelligence platform intelligently links these assertions with concepts from other structured data sources to provide a flexible data platform for CI professionals to investigate and analyze the data in the way that makes the most sense to them.
Singh and Szekely will demonstrate how these powerful and complimentary capabilities can help solve the problem of assessing which biomarkers are being studied across clinical trials in a specific therapeutic area.
Media and analysts interested in attending this webinar are encouraged to register online. For additional information, or to arrange a briefing with Cambridge Semantics, please contact Lora Friedrichsen at Cambridge(at)globalresultspr(dot)com or +1 949 608 0276.
About Cambridge Semantics
Cambridge Semantics is privately held and based in Boston, Massachusetts. For more information visit http://www.cambridgesemantics.com or follow us on Twitter @CamSemantics or Facebook.